Sean Bohen, Olema

Sean Bo­hen hauls in a mul­ti­mil­lion-dol­lar wind­fall as his new­ly adopt­ed biotech bags a $209M-plus IPO

Sean Bo­hen’s IPO for Ole­ma On­col­o­gy priced at $19 a share overnight, go­ing over the top of the range and giv­ing him an ini­tial mul­ti­mil­lion-dol­lar stake in the biotech as it ven­tures out in­to its first day of trad­ing on Thurs­day.

In their re­vised S-1 out a few days ago, the com­pa­ny did a re­verse split on his shares, leav­ing Bo­hen with an op­tion on 1,110,896 shares — about 3% of the com­pa­ny — at the re­con­fig­ured ex­er­cise price of $4.82. Those op­tions can be ex­er­cised with­in the next 40 days.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Alexandria Real Estate Equities

Cambridge, MA, USA